Jerrold R Turner

25PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityBio-fluidsCancer geneticsMicrobial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jan 06, 2026
Targeting MLCK1 uncouples immune checkpoint inhibitor-induced colitis from antitumour immunity.

Lei Xiong, Jianshang Huang, Yunsheng Dong

|Jul 17, 2025
Colitis-primed circulating T cells drive small intestinal barrier function through Nod2, microbiota and myosin light chain kinase-dependent mechanisms.

Arthur Mauduit, Talal Nabhani, Luisa Morelli

|May 07, 2024
A short guide to the tight junction.

Sandra Citi, Michael Fromm, Mikio Furuse

|Feb 27, 2024
Claudin-2 upregulation enhances intestinal permeability, immune activation, dysbiosis, and mortality in sepsis.

Takehiko Oami, Shabnam Abtahi, Takashi Shimazui

|May 15, 2023
Paracellular permeability and tight junction regulation in gut health and disease.

Arie Horowitz, Sandra D Chanez-Paredes, Xenia Haest

|May 03, 2023
WNT2B Deficiency Causes Increased Susceptibility to Colitis in Mice and Impairs Intestinal Epithelial Development in Humans.

Amy E O'Connell, Sathuwarman Raveenthiraraj, Comfort Adegboye

Pageof 5

Frequent Collaborators

3 joint publications

Wei-Ting Kuo

3 joint publications

Li Zuo

2 joint publications

Sandra D Chanez-Paredes

2 joint publications

Matthew K Waldor